X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12533) 12533
Book Chapter (107) 107
Dissertation (23) 23
Publication (22) 22
Magazine Article (21) 21
Conference Proceeding (14) 14
Newsletter (6) 6
Book / eBook (3) 3
Streaming Video (2) 2
Web Resource (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9746) 9746
follicular lymphoma (5283) 5283
female (4604) 4604
male (4542) 4542
middle aged (4085) 4085
oncology (3566) 3566
adult (3324) 3324
aged (3216) 3216
hematology (3036) 3036
lymphoma, follicular - pathology (2451) 2451
lymphomas (2032) 2032
rituximab (1824) 1824
pathology (1804) 1804
lymphoma (1666) 1666
non-hodgkins-lymphoma (1566) 1566
prognosis (1507) 1507
lymphoma, follicular - drug therapy (1456) 1456
cancer (1379) 1379
lymphoma, follicular - genetics (1332) 1332
aged, 80 and over (1306) 1306
b-cell lymphoma (1280) 1280
antineoplastic combined chemotherapy protocols - therapeutic use (1181) 1181
chemotherapy (1166) 1166
treatment outcome (1163) 1163
immunohistochemistry (1139) 1139
expression (1089) 1089
animals (1082) 1082
survival (995) 995
lymphoma, follicular - diagnosis (956) 956
lymphoma, follicular - therapy (932) 932
immunology (927) 927
adolescent (784) 784
chronic lymphocytic-leukemia (782) 782
diagnosis (768) 768
diagnosis, differential (766) 766
antineoplastic agents - therapeutic use (762) 762
retrospective studies (739) 739
translocation, genetic (729) 729
therapy (726) 726
lymphoma, follicular - mortality (706) 706
neoplasm staging (692) 692
disease-free survival (684) 684
research (673) 673
apoptosis (645) 645
care and treatment (643) 643
lymphoma, b-cell - pathology (628) 628
analysis (608) 608
medicine & public health (597) 597
polymerase chain reaction (595) 595
antibodies, monoclonal - therapeutic use (586) 586
lymph nodes - pathology (576) 576
lymphoma, non-hodgkin - pathology (576) 576
non-hodgkin's lymphomas (573) 573
hemic and lymphatic diseases (567) 567
cell biology (565) 565
mice (563) 563
lymphoma, follicular - immunology (562) 562
biopsy (555) 555
follow-up studies (549) 549
transplantation (540) 540
antibodies, monoclonal, murine-derived (536) 536
lymphoma, large b-cell, diffuse - pathology (532) 532
tumors (530) 530
young adult (521) 521
gene (515) 515
lymphoma, follicular - metabolism (514) 514
abridged index medicus (512) 512
combined modality therapy (512) 512
leukemia (510) 510
child (505) 505
survival analysis (503) 503
survival rate (489) 489
lymphoma, follicular (473) 473
risk factors (470) 470
disease (467) 467
lymphoma, b-cell - genetics (462) 462
mutation (457) 457
immunophenotyping (447) 447
lymphocytes (440) 440
immunotherapy (436) 436
anti-cd20 monoclonal-antibody (432) 432
lymphoma, non-hodgkin - drug therapy (430) 430
bcl-2 (428) 428
classification (427) 427
t (425) 425
flow cytometry (423) 423
low-grade (421) 421
recurrence (418) 418
non-hodgkin-lymphoma (417) 417
t cells (416) 416
cyclophosphamide (413) 413
gene expression (413) 413
surgery (413) 413
health aspects (407) 407
b-lymphocytes - immunology (406) 406
remission induction (403) 403
b-cells (402) 402
cyclophosphamide - administration & dosage (397) 397
disease progression (388) 388
medicine, research & experimental (387) 387
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11620) 11620
German (300) 300
French (238) 238
Japanese (221) 221
Spanish (126) 126
Chinese (99) 99
Italian (99) 99
Russian (93) 93
Czech (33) 33
Polish (33) 33
Korean (31) 31
Portuguese (29) 29
Hungarian (14) 14
Dutch (10) 10
Romanian (10) 10
Danish (8) 8
Turkish (6) 6
Norwegian (5) 5
Bulgarian (4) 4
Croatian (3) 3
Serbian (3) 3
Swedish (3) 3
Bosnian (2) 2
Finnish (2) 2
Slovak (2) 2
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Primary care, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
American journal of hematology, ISSN 0361-8609, 2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | MULTIPLE-MYELOMA | chronic lymphocytic leukemia (CLL) | acute lymphoblastic leukemia (ALL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SOMATIC MUTATIONS | TRANSCRIPTIONAL FINGERPRINTS | diffuse large B-cell lymphoma (DLBCL) | burkitt lymphoma (BL) | BURKITT-LYMPHOMA | gene regulation | circular RNA | POOR-PROGNOSIS | PROFILING REVEALS | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM) | EXPRESSION | PROMOTES | LNCRNA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites
Journal Article
Journal Article
Investigational new drugs, ISSN 1573-0646, 2018, Volume 37, Issue 2, pp. 297 - 306
...) dimer, in patients with relapsed or refractory (R/R) CD70-positive non-Hodgkin lymphoma (NHL... 
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Diffuse | large B cell | ONCOLOGY | lymphoma (DLBCL) | PLUS RITUXIMAB | PHARMACOLOGY & PHARMACY | OUTCOMES | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism | Lymphoma, B-Cell - drug therapy | CD27 Ligand - immunology | Lymphoma, B-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Recurrence, Local - metabolism | Antibodies, Monoclonal - pharmacokinetics | Lymphoma, Mantle-Cell - drug therapy | Maximum Tolerated Dose | Lymphoma, Mantle-Cell - immunology | Lymphoma, B-Cell - pathology | Benzodiazepines - chemistry | Pyrroles - chemistry | Aged | Drug Resistance, Neoplasm - drug effects | Thrombocytopenia | Anemia | Fatigue | Nausea | Exposure | Lymphoma | Patients | Anticancer properties | Membrane proteins | Proteins | Studies | Lymphocytes B | Mantle cell lymphoma | Antitumor activity | Remission | Lymphomas | Dimers | Mantle | Drug dosages | B-cell lymphoma | Phase I Studies
Journal Article
Best practice & research. Clinical haematology, ISSN 1521-6926, 2011, Volume 24, Issue 2, pp. 147 - 163
Journal Article
Journal Article